1688 Letters Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus

First Page		Document Content
Immunosuppressants Recombinant proteins Arthritis Monoclonal antibodies Amgen Etanercept Infliximab Tumor necrosis factor-alpha Rheumatoid arthritis Medicine Biology Pharmacology		1688 Letters Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 76,07 KB Share Document on Facebook

	Your Activities of Daily Living (YADL): An Image-based Survey Technique for Patients with Arthritis Longqi Yang†,‡ , Diana Freed‡ , Alex Wu* , Judy Wu‡ , John P. Pollak‡ , Deborah Estrin†,‡ † Department * DocID: 1xURC - View Document
	Rheumatoide Arthritis Mobil gegen Rheuma-Schmerz www.rheuma-liga.de DocID: 1vnGw - View Document
	CLINICAL TRIAL OUTCOME DATABASE (CTOD) Novartis RA: Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development Authors I Demin, B Hamren, O Luttringer, G Pillai and DocID: 1vbDv - View Document
	AMR Seminar #63 Case – 1 Contributed by: Abbas Agaimy, M.D. Clinical history: A 51-year-old woman presented with constitutional symptoms (unexplained fever, general illness and arthritis) thought to be of infectious et DocID: 1uN1f - View Document
	Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis Keywords: rheumatoid arthritis, autoimmune disease, GM-CSF, Th17, infl DocID: 1uFrU - View Document